Longfellow Investment Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3
Closed -$1.61K 281
2025
Q2
$1.61K Hold
3
﹤0.01% 233
2025
Q1
$1.26K Hold
3
﹤0.01% 244
2024
Q4
$1.24K Hold
3
﹤0.01% 250
2024
Q3
$1.52K Hold
3
﹤0.01% 227
2024
Q2
$1.46K Hold
3
﹤0.01% 220
2024
Q1
$1.62K Hold
3
﹤0.01% 232
2023
Q4
$1.67K Hold
3
﹤0.01% 208
2023
Q3
$1.31K Hold
3
﹤0.01% 205
2023
Q2
$1.51K Hold
3
﹤0.01% 226
2023
Q1
$1.5K Hold
3
﹤0.01% 230
2022
Q4
$1.22K Buy
+3
New +$1.17K ﹤0.01% 241
2022
Q2
Sell
-1
Closed -$1K 386
2022
Q1
$1K Hold
1
﹤0.01% 370
2021
Q4
$1K Buy
+1
New +$628 ﹤0.01% 372

Other funds holding IDXX

Longfellow Investment Management's IDXX Position: Q3 2025 in Review

Longfellow Investment Management sold out of Idexx Laboratories (IDXX) in Q3 2025, closing a stake of 3 shares — an estimated $1.61K sold.

Longfellow Investment Management first reported a position in IDXX in Q4 2021 and held it in 13 quarters. The position peaked at $1.67K in Q4 2023. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • Longfellow Investment Management reported no remaining Idexx Laboratories position as of Q3 2025 after selling out during the quarter.
  • Longfellow Investment Management sold 3 Idexx Laboratories shares in Q3 2025, an estimated $1.61K.
  • Longfellow Investment Management first reported a position in Idexx Laboratories in Q4 2021 and held it in 13 quarters.
  • Longfellow Investment Management's Idexx Laboratories position peaked at $1.67K in Q4 2023.
  • 1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Longfellow Investment Management's 13F filing for Q3 2025, filed 12 Nov 2025.